Nutrien Other Stockholder Equity vs Total Liab Analysis
NTR Stock | CAD 76.24 0.13 0.17% |
Nutrien financial indicator trend analysis is infinitely more than just investigating Nutrien recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nutrien is a good investment. Please check the relationship between Nutrien Other Stockholder Equity and its Total Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutrien. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Nutrien Stock, please use our How to Invest in Nutrien guide.
Other Stockholder Equity vs Total Liab
Other Stockholder Equity vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nutrien Other Stockholder Equity account and Total Liab. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Nutrien's Other Stockholder Equity and Total Liab is -0.52. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Total Liab in the same time period over historical financial statements of Nutrien, assuming nothing else is changed. The correlation between historical values of Nutrien's Other Stockholder Equity and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Nutrien are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Other Stockholder Equity i.e., Nutrien's Other Stockholder Equity and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.52 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Other Stockholder Equity
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from Nutrien's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nutrien current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutrien. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Nutrien Stock, please use our How to Invest in Nutrien guide.At this time, Nutrien's Selling General Administrative is very stable compared to the past year. As of the 9th of June 2024, Discontinued Operations is likely to grow to about 4.4 B, while Tax Provision is likely to drop about 608.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 9.4B | 15.4B | 8.5B | 8.9B | Total Revenue | 27.7B | 37.9B | 29.1B | 30.5B |
Nutrien fundamental ratios Correlations
Click cells to compare fundamentals
Nutrien Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Nutrien fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 46.8B | 47.2B | 50.0B | 54.6B | 52.7B | 55.4B | |
Short Long Term Debt Total | 11.1B | 11.4B | 10.8B | 11.9B | 13.7B | 14.4B | |
Other Current Liab | 1.7B | 1.8B | 2.8B | 3.2B | 16M | 15.2M | |
Total Current Liabilities | 9.1B | 8.5B | 12.4B | 14.3B | 12.1B | 12.7B | |
Total Stockholder Equity | 22.9B | 22.4B | 23.7B | 25.8B | 25.2B | 26.4B | |
Property Plant And Equipment Net | 20.3B | 19.7B | 20.0B | 21.8B | 22.5B | 23.6B | |
Net Debt | 10.4B | 9.9B | 10.3B | 11.0B | 10.3B | 10.8B | |
Retained Earnings | 7.1B | 6.6B | 8.2B | 11.9B | 11.5B | 12.1B | |
Cash | 671M | 1.5B | 499M | 901M | 941M | 988.1M | |
Non Current Assets Total | 36.1B | 35.7B | 36.1B | 38.2B | 38.6B | 40.5B | |
Non Currrent Assets Other | 315M | 672M | 567M | 521M | 345M | 457.0M | |
Cash And Short Term Investments | 671M | 1.5B | 499M | 901M | 1.0B | 1.1B | |
Net Receivables | 3.5B | 3.6B | 5.4B | 6.2B | 4.7B | 4.9B | |
Common Stock Shares Outstanding | 583.1M | 569.7M | 571.3M | 540.0M | 494.6M | 420.2M | |
Liabilities And Stockholders Equity | 46.8B | 47.2B | 50.0B | 54.6B | 62.8B | 65.9B | |
Non Current Liabilities Total | 14.8B | 16.3B | 13.8B | 14.4B | 15.4B | 16.2B | |
Inventory | 5.0B | 4.9B | 6.3B | 7.6B | 6.3B | 6.7B | |
Other Current Assets | 1.5B | 1.5B | 1.7B | 1.6B | 1.5B | 1.6B | |
Other Stockholder Equity | 248M | 205M | 149M | 109M | 98.1M | 93.2M | |
Total Liab | 23.9B | 24.8B | 26.3B | 28.7B | 27.5B | 28.9B | |
Property Plant And Equipment Gross | 20.3B | 19.7B | 34.8B | 37.2B | 39.3B | 41.3B | |
Total Current Assets | 10.7B | 11.5B | 13.8B | 16.3B | 14.2B | 14.9B | |
Accumulated Other Comprehensive Income | (251M) | (119M) | (146M) | (391M) | (449.7M) | (427.2M) | |
Accounts Payable | 4.0B | 4.4B | 5.2B | 5.8B | 5.5B | 5.8B | |
Intangible Assets | 2.4B | 2.4B | 2.3B | 2.3B | 2.2B | 2.3B | |
Good Will | 12.0B | 12.2B | 12.2B | 12.4B | 12.1B | 12.7B | |
Short Term Debt | 1.7B | 422M | 2.4B | 3.0B | 3.4B | 3.6B | |
Current Deferred Revenue | 1.7B | 1.8B | 2.1B | 2.3B | 2.6B | 2.8B | |
Common Stock Total Equity | 1.8B | 16.7B | 15.8B | 15.7B | 18.0B | 18.9B | |
Common Stock | 15.8B | 15.7B | 15.5B | 14.2B | 16.3B | 8.8B | |
Other Liab | 5.4B | 5.4B | 5.4B | 5.5B | 6.3B | 4.9B | |
Net Tangible Assets | 8.5B | 7.8B | 9.1B | 11.2B | 12.8B | 9.9B | |
Other Assets | 564M | 914M | 829M | 811M | 932.7M | 556.3M | |
Long Term Debt | 8.6B | 10.0B | 7.5B | 8.0B | 8.9B | 6.8B | |
Long Term Investments | 821M | 562M | 703M | 843M | 736M | 1.1B | |
Short Long Term Debt | 1.5B | 173M | 2.1B | 2.7B | 2.3B | 1.5B | |
Property Plant Equipment | 20.3B | 19.7B | 20.0B | 21.8B | 25.0B | 18.1B | |
Non Current Liabilities Other | 161M | 209M | 207M | 235M | 200M | 176.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Nutrien Stock
When determining whether Nutrien is a strong investment it is important to analyze Nutrien's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nutrien's future performance. For an informed investment choice regarding Nutrien Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutrien. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Nutrien Stock, please use our How to Invest in Nutrien guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.